Stocktwits on MSN
Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise
VKTX shares have surged about 45% in October, set for their strongest monthly gain of 2025. ・Traders on Stocktwits linked ...
Viking Therapeutics (VKTX 0.37%) leaped onto center stage early last year when it announced promising news about a candidate addressing an area of soaring demand: weight loss. The ...
River cruise operator Viking went public at $24 earlier this month. Viking caters to an entirely different market from Carnival, and that could be a good thing. With more than half of its passengers ...
Viking Therapeutics, Inc. stock has surged nearly 1,500% since 2023, driven by the promising GLP-1/GIP receptor agonist VK-2735 for obesity. VK-2735's Phase 2 data showed weight loss comparable to ...
Viking Therapeutics' stock initially surged after positive Phase 2 data for its obesity drug, but fell after Novo Nordisk shared data on a new, oral weight loss drug. Eli Lilly and Novo Nordisk have ...
Hosted on MSN
Market Bloodbath: Viking Therapeutics Stock Tanks After Obesity Pill Side Effects Trigger Mass Dropouts
Viking Therapeutics (NASDAQ: VKTX) suffered a brutal market sell-off on Tuesday, with shares plunging over 40% in one of the biotech firm's steepest single-day drops since its initial public offering ...
Financial giants have made a conspicuous bullish move on Viking Therapeutics. Our analysis of options history for Viking Therapeutics VKTX revealed 12 unusual trades. Delving into the details, we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback